share_log

オリンパス社員による過敏性腸症候群と大腸ポリープの体験談を取り上げた新たな「True to Life ストーリー」を公開

A new 'True to Life Story' featuring experiences of Olympus employees with irritable bowel syndrome and colorectal polyps has been released.

OLYMPUS ·  Oct 20 23:00

October 21, 2024

nr02762_00000.png
Olympus employee Takayama Miho

Olympus Co., Ltd. (hereafter, Olympus) has released the latest episode of “True to Life Story,” which introduces cases of contributing to the healthy and rich lives of people around the world by providing advanced medical technology and solutions. In this story, we are taking up the treatment experience of Miho Takayama, an Olympus employee.

Mr. Takayama has been dealing with irritable bowel syndrome since her late 20s. When I was 35 years old, when I underwent an endoscopy, I found a polyp in my large intestine. I interviewed Mr. Takayama, who said, “I felt the importance of being sensitive to changes in my body,” about what she keeps in mind on a daily basis, and introduced it as an article.
In addition to the official Olympus website, this story is also posted on LinkedIn and X, so be sure to check it out.
Olympus began sending out a global brand message called “True to Life” in December 2021, and is developing various measures aimed at raising brand awareness as a global medtech company, and the “True to Life Story” is regularly published as part of this activity. You can view past stories from the links below.

* Published content is current information as of the date of publication, and information may have changed (end of production/sales, changes in specifications, prices, etc.) without notice at the time of viewing.

※ The published content is information announced to members of the press, shareholders, investors, etc. Information on medical devices (including products not approved by the Pharmaceuticals and Medical Devices Act) may be included, but the content is not intended for advertising or medical advice.

※ We are not responsible for any damage caused as a result of using the posted content.

* Company names and product names published in this release are trademarks or registered trademarks of their respective companies.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment